Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
104.32
+0.69 (0.67%)
Jul 3, 2025, 1:00 PM - Market closed

Boston Scientific Market Cap

Boston Scientific has a market cap or net worth of $154.34 billion as of July 3, 2025. Its market cap has increased by 37.78% in one year.

Market Cap
154.34B
Enterprise Value
165.32B
1-Year Change
37.78%
Ranking
Category
Stock Price
$104.32

Market Cap Chart

Since December 1, 1998, Boston Scientific's market cap has increased from $10.63B to $154.34B, an increase of 1,351.56%. That is a compound annual growth rate of 10.58%.

History

DateMarket Cap% Change
Jul 3, 2025154.34B17.24%
Dec 31, 2024131.64B55.44%
Dec 29, 202384.69B27.79%
Dec 30, 202266.27B9.48%
Dec 31, 202160.53B17.59%
Dec 31, 202051.48B-18.33%
Dec 31, 201963.03B28.88%
Dec 31, 201848.90B43.66%
Dec 29, 201734.04B15.58%
Dec 30, 201629.45B18.74%
Dec 31, 201524.81B41.13%
Dec 31, 201417.58B9.51%
Dec 31, 201316.05B104.00%
Dec 31, 20127.87B-0.56%
Dec 30, 20117.91B-31.25%
Dec 31, 201011.51B-15.35%
Dec 31, 200913.59B16.97%
Dec 31, 200811.62B-32.97%
Dec 31, 200717.34B-31.53%
Dec 29, 200625.32B26.18%
Dec 30, 200520.07B-33.15%
Dec 31, 200430.02B-0.30%
Dec 31, 200330.11B73.64%
Dec 31, 200217.34B78.25%
Dec 31, 20019.73B75.34%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 306.47B
UnitedHealth Group 279.90B
Novartis AG 238.56B
Abbott Laboratories 233.90B
AstraZeneca 216.08B
Market Cap Rankings